Market closed
Axogen/$AXGN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Axogen
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Ticker
$AXGN
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
452
Website
Axogen Metrics
BasicAdvanced
$834M
-
-$0.23
0.99
-
Price and volume
Market cap
$834M
Beta
0.99
52-week high
$21.00
52-week low
$5.55
Average daily volume
590K
Financial strength
Current ratio
3.241
Quick ratio
1.881
Long term debt to equity
66.518
Total debt to equity
68.413
Interest coverage (TTM)
-0.40%
Management effectiveness
Return on assets (TTM)
-1.03%
Return on equity (TTM)
-9.99%
Valuation
Price to revenue (TTM)
4.441
Price to book
7.99
Price to tangible book (TTM)
8.44
Price to free cash flow (TTM)
75,806.452
Growth
Revenue change (TTM)
17.81%
Earnings per share change (TTM)
-54.90%
3-year revenue growth (CAGR)
13.73%
3-year earnings per share growth (CAGR)
-29.44%
What the Analysts think about Axogen
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Axogen stock.
Axogen Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Axogen Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Axogen News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Axogen stock?
Axogen (AXGN) has a market cap of $834M as of March 28, 2025.
What is the P/E ratio for Axogen stock?
The price to earnings (P/E) ratio for Axogen (AXGN) stock is 0 as of March 28, 2025.
Does Axogen stock pay dividends?
No, Axogen (AXGN) stock does not pay dividends to its shareholders as of March 28, 2025.
When is the next Axogen dividend payment date?
Axogen (AXGN) stock does not pay dividends to its shareholders.
What is the beta indicator for Axogen?
Axogen (AXGN) has a beta rating of 0.99. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.